Department of Neurology Xuanwu Hospital Capital Medical University Beijing China.
Beijing Key Laboratory of Hypoxic Conditioning Translational Medicine Xuanwu Hospital Capital Medical University Beijing China.
Ann Clin Transl Neurol. 2018 Nov 15;6(1):186-196. doi: 10.1002/acn3.691. eCollection 2019 Jan.
Despite great improvement during the past several decades, the management of stroke is still far from satisfactory, which warrants alternative or adjunctive strategies. Remote ischemic conditioning (RIC), an easy-to-use and noninvasive therapy, can be performed in various clinical scenarios (e.g., prehospital transportation, intrahospital, and at home), and it has been widely investigated for stroke management. RIC has been demonstrated to be well tolerated in patients with acute ischemic stroke and aneurysm subarachnoid hemorrhage, and it may benefit these patients by improving clinical outcomes; in patients with intracranial atherosclerosis, long-term repeated RIC could be safely performed and benefit patients by reducing recurrent ischemic stroke and transient ischemic attack, as well as improving cerebral perfusion status; long-term repeated RIC may also benefit patients with cerebral small vessel disease by slowing cognitive decline and reducing volume of white matter hyperintensities on brain MRI; in patients with severe carotid atherosclerotic stenosis undergoing stenting, preprocedural RIC could reduce the odds of new brain lesions on postprocedural MRI. Previous clinical studies suggest broad future prospects of RIC in the field of cerebrovascular diseases. However, the optimal RIC protocol and the mechanisms that RIC protects the brain is not fully clear, and there is lack of sensitive and specific biomarkers of RIC, all these dilemmas prevent RIC from entering clinical practice. This review focuses on recent advances in clinical studies of RIC in stroke management, its challenges, and the potential directions of future studies.
尽管在过去几十年中取得了巨大进展,但脑卒中的治疗仍然远不能令人满意,因此需要替代或辅助策略。远程缺血预处理(RIC)是一种易于使用且非侵入性的治疗方法,可在各种临床情况下(如院前转运、院内和家庭)进行,并且已广泛用于脑卒中的治疗。RIC 已被证明在急性缺血性脑卒中患者和蛛网膜下腔出血的动脉瘤患者中耐受良好,通过改善临床结局,可能使这些患者受益;在颅内动脉粥样硬化患者中,长期重复 RIC 可以安全进行,并通过减少复发性缺血性卒中和短暂性脑缺血发作,以及改善脑灌注状态,使患者受益;长期重复 RIC 还可以通过减缓认知能力下降和减少脑 MRI 上的脑白质高信号体积,使脑小血管病患者受益;在接受支架置入术的严重颈动脉粥样硬化狭窄患者中,术前 RIC 可降低术后 MRI 上新的脑损伤的可能性。以前的临床研究表明,RIC 在脑血管疾病领域具有广阔的应用前景。然而,最佳的 RIC 方案和 RIC 保护大脑的机制尚不完全清楚,并且缺乏 RIC 的敏感和特异性生物标志物,所有这些困境都阻止了 RIC 进入临床实践。本综述重点介绍了 RIC 在脑卒中治疗中的临床研究进展、挑战以及未来研究的潜在方向。